Routine Angiography Follow-Up After Percutaneous Coronary Intervention in High-Risk Patients

NCT05923489 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2618

Last updated 2026-08-21

No results posted yet for this study

Summary

Comparison of clinical outcomes between routine angiography follow-up and routine clinical follow-up after percutaneous coronary intervention in high-risk patients.

Conditions

Interventions

DIAGNOSTIC_TEST

Routine Angiography Follow-up

Patients in the RAF group will have routine angiography follow-up at 12±3 months after revascularization.

DIAGNOSTIC_TEST

Routine Clinical Follow-up

Patients in the RCF group will have routine clinical follow-up at 12±3 months after revascularization, and the further interventions can be performed at the discretion of the physician according to the current standard.

Sponsors & Collaborators

  • Jinhua Central Hospital

    collaborator OTHER
  • Changxing People's Hospital

    collaborator OTHER
  • The Affiliated Hospital of Hangzhou Normal University

    collaborator OTHER
  • Second Affiliated Hospital of Shantou University Medical College

    collaborator OTHER
  • Dongyang People's Hospital

    collaborator OTHER
  • First Affiliated Hospital of Wenzhou Medical University

    collaborator OTHER
  • Huzhou Central Hospital

    collaborator OTHER
  • First Affiliated Hospital of Ningbo University

    collaborator NETWORK
  • The First People's Hospital of Linping District

    collaborator UNKNOWN
  • The Sixth People's Hospital of Xinjiang Uygur Autonomous Region

    collaborator UNKNOWN
  • Ningbo Medical Center Lihuili Hospital

    collaborator OTHER_GOV
  • The Eighth People's Hospital of JiNan

    collaborator UNKNOWN
  • The First Affiliated Hospital of Nanchang University

    collaborator OTHER
  • Ruian People's Hospital of Zhejiang Province

    collaborator UNKNOWN
  • Shaoxing Central Hospital

    collaborator OTHER
  • The Second People's Hospital of Quzhou

    collaborator UNKNOWN
  • Second Affiliated Hospital, Zhejiang University, School of Medicine

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-26
Primary Completion
2028-12-30
Completion
2029-10-15

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05923489 on ClinicalTrials.gov